Throughout 2018 EKG Labs has been traveling the country, attending a wide variety of pharmaceutical and medical device conferences. Dr. Allen Kesselring, Chief Science Officer at EKG Labs, attended Smithers Rapra’s E&L USA 2018 and presented on the evolution and challenges of USP <661.1> and <661.2> at PharmaEd’s Extractables, Leachables & Elemental Impurities 2018 — East Coast. Dr. Kesselring will be presenting this talk again for the West Coast at Extractables, Leachables & Elemental Impurities 2018 — West Coast in La Jolla, November 13-14. At the Medical Device Technology Exchange (MDTX) Conference and Exhibition, Dr. Kesselring presented on medical device material compatibility. Most recently, EKG Labs attended PharmaED’s Transdermal and Intradermal Drug Delivery Systems.
At this conference, EKG’s Dr. Xiao Jia presented “Regulatory and Experimental Considerations for Extractable and Leachable Analysis of Microneedle Patches: A Case Study”. This presentation included discussion on defining and classifying microneedles, an exploration of guidelines that apply to microneedles, considerations for E&L microneedle studies, and an overview of an EKG Labs case study performed on commercially available microneedle patches. Some preliminary results from this case study are already summarized online, though the final results were presented at the conference. The microneedle case study will also be presented as a poster at AAPS PharmSci 360 in Washington, D.C. on November 6th (poster number T1530-08-063, 3:30 – 4:30 pm).
If you would like to talk with us more about any of these topics or are interested in obtaining a copy of our presentations, please let us know.
One of our favorite elements of these conferences is the opportunity to meet both current and prospective clients face-to-face. When not in a session, you can be sure to find us exploring the exhibit halls and networking over coffee. If you would like to meet with Dr. Kesselring or our CEO, Ms. Katie Grayson, at AAPS in Washington D.C. or in La Jolla during the PharmEd conference to discuss your extractable/leachable questions or any other analytical needs, please drop us a note. We’ll see you there!
About EKG Labs
EKG Labs is an analytical service provider for the pharmaceutical and medical device industries. Our analytical services support product development, regulatory filings, and analytical chemistry investigations. EKG Labs operates out of Innovative Technology Enterprises (ITE) at the University of Missouri, St. Louis (UMSL).
Some of our services include:
- Extractables and Leachables Analysis
- Impurity Identification
- Material/Chemical Characterization
- Method Development and Validation
To find out how EKG Labs can help you with your product development and regulatory needs, contact us at 810-354-5229.